PropertyValue
?:abstract
  • A large-scale screening campaign has yielded dozens of crystal structures of small molecule fragments that bind to the main protease of SARS-CoV-2. The global research community is encouraged to pursue these as drug discovery starting points for COVID-19.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1038/s41467-020-18710-3
?:journal
  • Nat_Commun
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/a3e86ccc7587b9440c281d55afa607aad7305e31.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7541474.xml.json
?:pmcid
?:pmid
?:pmid
  • 33028832.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • Many small steps towards a COVID-19 drug
?:type
?:year
  • 2020-10-07

Metadata

Anon_0  
expand all